What Researchers Did
Researchers compared drug treatment alone versus drug treatment combined with hyperbaric oxygen therapy in 120 sudden deafness patients over two weeks.
What They Found
The combined therapy group (83.33%, 50/60) showed a significantly higher effective rate compared to the drug-only group (60.00%, 36/60). This difference was particularly evident in patients with moderate and severe deafness, but not in those with mild or profound hearing loss.
What This Means for Canadian Patients
This study suggests that adding hyperbaric oxygen therapy to standard drug treatment could improve outcomes for Canadian patients experiencing sudden deafness, especially those with moderate to severe hearing loss. Patients should discuss with their healthcare providers whether this combined approach is a suitable treatment option for their specific condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted elsewhere.
Study Limitations
The study's limitations include a relatively small sample size of 120 patients and a short two-week treatment duration.